Human T-cell lymphotropic virus: A model of NF-κB-associated tumorigenesis

Viruses

Volumn 3, Issue 6, 2011, Pages 714-749

  Qu, Zhaoxia ^a,b   Xiao, Gutian ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

ATL; HTLV; IKK; Immune escape; NF B; PDLIM2; Tax; Transformation; Tumorigenesis; Virus host interaction; WWOX

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; TAX PROTEIN;

ARTICLE; CELL TRANSFORMATION; GENE ACTIVATION; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; LEUKEMOGENESIS; NONHUMAN; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; SUMOYLATION; T CELL LEUKEMIA; UBIQUITINATION; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS ONCOGENE; VIRUS PATHOGENESIS;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MODELS, BIOLOGICAL; NF-KAPPA B;

DELTARETROVIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2;

EID: 79959668389     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v3060714     Document Type: Article

References (263)

1. Gallo, R. History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2. Oncogene 2005, 24, 5926-5930.
2. Feuer, G.; Green, P.L. Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2. Oncogene 2005, 24, 5996-56004.
3. Oh, U.; Jacobson, S. Treatment of HTLV-I-associated myelopathy/tropical spastic paraparesis: Toward rational targeted therapy. Neurol. Clin. 2008, 26, 781-797.
4. Tsukasaki, K.; Hermine, O.; Bazarbachi, A.; Ratner, L.; Ramos, J.C.; Harrington, W., Jr.; O'Mahony, D.; Janik, J.E.; Bittencourt, A.L.; Taylor, G.P. et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: A proposal from an international consensus meeting. J. Clin. Oncol. 2009, 27, 453-459.
5. Goncalves, D.U.; Proietti, F.A.; Ribas, J.G.; Araujo, M.G.; Pinheiro, S.R.; Guedes, A.C.; Carneiro-Proietti, A.B. Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin. Microbiol. Rev. 2010, 23, 577-589.
6. Burmeister, T. Oncogenic retroviruses in animals and humans. Rev. Med. Virol. 2001, 11, 369-380.
7. Sun, S.C.; Yamaoka, S. Activation of NF-kappaB by HTLV-I and implications for cell transformation. Oncogene 2005, 24, 5952-5964.
8. Matsuoka, M., Jeang, K.T. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer 2007, 7, 270-280.
9. Higuchi, M.; Fujii, M. Distinct functions of HTLV-1 Tax1 from HTLV-2 Tax2 contribute key roles to viral pathogenesis. Retrovirology 2009, 6, 117.
10. Pozzatti, R.; Vogel, J.; Jay, G. The human T-lymphotropic virus type I tax gene can cooperate with the ras oncogene to induce neoplastic transformation of cells. Mol. Cell Biol. 1990, 10, 413-417.
11. Grassmann, R.; Berchtold, S.; Radant, I.; Alt, M.; Fleckenstein, B.; Sodroski, J.G.; Haseltine, W.A.; Ramstedt, U. Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture. J. Virol. 1992, 66, 4570-4575.
12. Akagi, T.; Shimotohno, K. Proliferative response of Tax1-transduced primary human T cells to anti-CD3 antibody stimulation by an interleukin-2-independent pathway. J. Virol. 1993, 67, 1211-1217.
13. Tanaka, A.; Takahashi, C.; Yamaoka, S.; Nosaka, T.; Maki, M.; Hatanaka, M. Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro. Proc. Natl. Acad. Sci. U. S. A. 1990, 87, 1071-1075.
14. Fujita, M.; Shiku, H. Differences in sensitivity to induction of apoptosis among rat fibroblast cells transformed by HTLV-I tax gene or cellular nuclear oncogenes. Oncogene 1995, 11, 15-20.
15. Oka, T.; Sonobe, H.; Iwata, J.; Kubonishi, I.; Satoh, H.; Takata, M.; Tanaka, Y.; Tateno, M.; Tozawa, H.; Mori, S. et al. Phenotypic progression of a rat lymphoid cell line immortalized by human T-lymphotropic virus type I to induce lymphoma/leukemia-like disease in rats. J. Virol. 1992, 66, 6686-6694.
16. Yamaoka, S.; Tobe, T.; Hatanaka, M. Tax protein of human T-cell leukemia virus type I is required for maintenance of the transformed phenotype. Oncogene 1992, 7, 433-437.
17. Nerenberg, M.; Hinrichs, S.H.; Reynolds, R.K.; Khoury, G.; Jay, G. The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science 1987, 237, 1324-1329.
18. Hinrichs, S.H.; Nerenberg, M.; Reynolds, R.K.; Khoury, G.; Jay, G. A transgenic mouse model for human neurofibromatosis. Science 1987, 237, 1340-1343.
19. Peebles, R.S.; Maliszewski, C.R.; Sato, T.A.; Hanley-Hyde, J.; Maroulakou, I.G.; Hunziker, R.; Schneck, J.P.; Green, J.E. Abnormal B-cell function in HTLV-I-tax transgenic mice. Oncogene 1995, 10, 1045-1051.
20. Grossman, W.J.; Kimata, J.T.; Wong, F.H.; Zutter, M.; Ley, T.J.; Ratner, L. Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. U. S. A. 1995, 92, 1057-1061.
21. Iwakura, Y.; Tosu, M.; Yoshida, E.; Saijo, S.; Nakayama-Yamada, J.; Itagaki, K.; Asano, M.; Siomi, H.; Hatanaka, M.; Takeda, T. et al. Augmentation of c-fos and c-jun expression in transgenic mice carrying the human T-cell leukemia virus type-I tax gene. Virus Genes 1995, 9, 161-170.
22. Hall, A.P.; Irvine, J.; Blyth, K.; Cameron, E.R.; Onions, D.E.; Campbell, M.E. Tumours derived from HTLV-I tax transgenic mice are characterized by enhanced levels of apoptosis and oncogene expression. J. Pathol. 1998, 186, 209-214.
23. Hasegawa, H.; Sawa, H.; Lewis, M.J.; Orba, Y.; Sheehy, N.; Yamamoto, Y.; Ichinohe, T.; Tsunetsugu-Yokota, Y.; Katano, H.; Takahashi, H. et al. Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat. Med. 2006, 12, 466-472.
24. Banerjee, P.; Tripp, A.; Lairmore, M.D.; Crawford, L.; Sieburg, M.; Ramos, J.C.; Harrington, W., Jr.; Beilke, M.A.; Feuer, G. Adult T-cell leukemia/lymphoma development in HTLV-1-infected humanized SCID mice. Blood 2010, 115, 2640-2648.
25. Akagi, T.; Ono, H.; Shimotohno, K. Characterization of T cells immortalized by Tax1 of human T-cell leukemia virus type 1. Blood 1995, 86, 4243-4249.
26. Xiao, G.; Rabson, A.B.; Young, W.; Qing, G.; Qu, Z. Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease. Cytokine Growth Factor Rev. 2006, 17, 281-293.
27. Xiao, G.; Fu, J. NF-kappaB and Cancer: A Paradigm of Yin-Yang. Am. J. Cancer Res. 2011, 1, 192-221.
28. Rice, N.R.; MacKichan, M.L.; Israel, A. The precursor of NF-kappa B p50 has I kappa B-like functions. Cell 1992, 71, 243-253.
29. Mercurio, F.; DiDonato, J.A.; Rosette, C.; Karin, M. p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction. Genes Dev. 1993, 7, 705-718.
30. Heissmeyer, V.; Krappmann, D.; Hatada, E.N.; Scheidereit, C. Shared pathways of Ikappa B kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappa B precursor p105 and I kappa Balpha. Mol. Cell Biol. 2001, 21, 1024-1035.
31. Sriskantharajah, S.; Belich, M.P.; Papoutsopoulou, S.; Janzen, J.; Tybulewicz, V.; Seddon, B.; Ley, S.C. Proteolysis of NF-kappaB1 p105 is essential for T cell antigen receptor-induced proliferation. Nat. Immunol. 2009, 10, 38-47.
32. Xiao, G.; Harhaj, E.W.; Sun, S.C. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol. Cell 2001, 7, 401-409.
33. Qing, G.; Qu, Z.; Xiao, G. Regulation of NF-kappa B2 p100 processing by its cis-acting domain. J. Biol. Chem. 2005, 280, 18-27.
34. Pahl, H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18, 6853-6866.
35. Chen, Z.J. Ubiquitin signalling in the NF-kappa B pathway. Nat. Cell Biol. 2005, 7, 758-765.
36. Wuerz berger-Davis, S.M.; Miyamoto, S. TAK-ling IKK activation: Ub the judge. Sci. Signal 2010, 3, pe 3.
37. Israel, A. The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb. Perspect. Biol. 2010, 2, a000158.
38. Zhong, H.; May, M.J; Jimi, E.; Ghosh, S. The phosphorylation status of nuclear NF-kappaB determines its association with CBP/p300 or HDAC-1. Mol. Cell 2002, 9, 625-636.
39. Ashburner, B.P.; Westerheide, S.D.; Baldwin, A.S., Jr. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol. Cell Biol. 2001, 21, 7065-7077.
40. Ryo, A.; Suizu, F.; Yoshida, Y.; Perrem, K.; Liou, Y.C.; Wulf, G.; Rottapel, R.; Yamaoka, S.; Lu, K.P. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 2003, 12, 1413-1426.
41. Chen, L.F.; Fischle, W.; Verdin, E.; Greene, W.C. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 2001, 293, 1653-1657.
42. Qing, G.; Qu, Z.; Xiao, G. Stabilization of basally translated NF-kappaB-inducing kinase (NIK) protein functions as a molecular switch of processing of NF-kappaB2 p100. J. Biol. Chem. 2005, 280, 40578-40582.
43. Liao, G.; Zhang, M.; Harhaj, E.W.; Sun, S.C. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J. Biol. Chem. 2004, 279, 26243-26250.
44. Sun, S.C.; Ley, S.C. New insights into NF-kappaB regulation and function. Trends Immunol. 2008, 29, 469-478.
45. Xiao, G.; Sun S.C. Negative regulation of the nuclear factor kappa B-inducing kinase by a cis-acting domain. J. Biol. Chem. 2000, 19, 1448-1456.
46. Gardam, S.; Sierro, F.; Basten, A.; Mackay, F.; Brink, R. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. Immunity 2008, 28, 391-401.
47. Grech, A.P.; Amesbury, M.; Chan, T.; Gardam, S.; Basten, A.; Brink, R. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells. Immunity 2004, 21, 629-642.
48. He, J.Q.; Zarnegar, B.; Oganesyan, G.; Saha, S.K.; Yamazaki, S.; Doyle, S.E.; Dempsey, P.W.; Cheng, G. Rescue of TRAF3-null mice by p100 NF-kappa B deficiency. J. Exp. Med. 2006, 203, 2413-2418.
49. Moore, C.R.; Bishop, G.A. Differential regulation of CD40-mediated TNF receptor-associated factor degradation in B lymphocytes. J. Immunol. 2005, 175, 3780-3789.
50. Varfolomeev, E.; Blankenship, J.W.; Wayson, S.M.; Fedorova, A.V.; Kayagaki, N.; Garg, P.; Zobel, K.; Dynek, J.N.; Elliott, L.O.; Wallweber, H.J. et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 2007, 131, 669-681.
51. Vince, J.E.; Wong, W.W.; Khan, N.; Feltham, R.; Chau, D.; Ahmed, A.U.; Benetatos, C.A.; Chunduru, S.K.; Condon, S.M.; McKinlay, M. et al. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 2007, 131, 682-693.
52. Fong, A.; Sun, S.C., Genetic evidence for the essential role of beta-transducin repeat-containing protein in the inducible processing of NF-kappa B2/p100. J. Biol. Chem. 2002, 277, 22111-22114.
53. Senftleben, U.; Cao, Y.; Xiao, G.; Greten, F.R.; Krahn, G.; Bonizzi, G.; Chen, Y.; Hu, Y.; Fong, A.; Sun, S.C.; Karin, M. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 2001, 293, 1495-1499.
54. Xiao, G.; Fong, A.; Sun, S.C. Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation. J. Biol. Chem. 2004, 279, 30099-30105.
55. Zarnegar, B.; Yamazaki, S.; He, J.Q.; Cheng, G. Control of canonical NF-kappaB activation through the NIK-IKK complex pathway. Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 3503-3508.
56. Delhase, M.; Hayakawa, M.; Chen, Y.; Karin, M. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 1999, 284, 309-313.
57. Razani, B.; Zarnegar, B.; Ytterberg, A.J.; Shiba, T.; Dempsey, P.W.; Ware, C.F.; Loo, J.A.; Cheng, G. Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation. Sci. Signal 2010, 3, pe41.
58. Wertz, I.E.; O'Rourke, K.M.; Zhou, H.; Eby, M.; Aravind, L.; Seshagiri, S.; Wu, P.; Wiesmann, C.; Baker, R.; Boone, D.L. et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 2004, 430, 694-699.
59. Krikos, A.; Laherty, C.D.; Dixit, V.M. Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. J. Biol. Chem. 1992, 267, 17971-17976.
60. Shembade, N.; Ma, A.; Harhaj, E.W. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 2010, 327, 1135-1139.
61. Boone, D.L.; Turer, E.E.; Lee, E.G.; Ahmad, R.C.; Wheeler, M.T.; Tsui, C.; Hurley, P.; Chien, M.; Chai, S.; Hitotsumatsu, O. et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 2004, 5, 1052-1060.
62. Zhang, S.Q.; Kovalenko, A.; Cantarella, G.; Wallach, D. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. Immunity 2000, 12, 301-311.
63. Mauro, C.; Pacifico, F.; Lavorgna, A.; Mellone, S.; Iannetti, A.; Acquaviva, R.; Formisano, S.; Vito, P.; Leonardi, A. ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB. J. Biol. Chem. 2006, 281, 18482-18488.
64. Hutti, J.E.; Turk, B.E.; Asara, J.M.; Ma, A.; Cantley, L.C.; Abbott, D.W. IkappaB kinase beta phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-kappaB pathway. Mol. Cell Biol. 2007, 27, 7451-7461.
65. Sun, S.C. CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes. Cell Death Differ. 2010, 17, 25-34.
66. Brummelkamp, T.R.; Nijman, S.M.; Dirac, A.M.; Bernards, R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 2003, 424, 797-801.
67. Kovalenko, A.; Chable-Bessia, C.; Cantarella, G.; Israel, A.; Wallach, D.; Courtois, G. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 2003, 424, 801-805.
68. Trompouki, E.; Hatzivassiliou, E.; Tsichritzis, T.; Farmer, H.; Ashworth, A.; Mosialos, G. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 2003, 424, 793-796.
69. Chew, J.; Biswas, S.; Shreeram, S.; Humaidi, M.; Wong, E.T.; Dhillion, M.K.; Teo, H.; Hazra, A.; Fang, C.C.; López-Collazo, E. et al. WIP1 phosphatase is a negative regulator of NF-kappaB signalling. Nat. Cell Biol. 2009, 11, 659-666.
70. Li, S.; Wang, L.; Berman, M.A.; Zhang, Y.; Dorf, M.E. RNAi screen in mouse astrocytes identifies phosphatases that regulate NF-kappaB signaling. Mol. Cell 2006, 24, 497-509.
71. Yang, J.; Fang, G.H; Wadzinski, B.E.; Sakurai, H.; Richmond, A. Protein phosphatase 2A interacts with and directly dephosphorylates RelA. J. Biol. Chem. 2001, 276, 47828-47833.
72. Yeung, F.; Hoberg, J.E.; Ramsey, C.S.; Keller, M.D.; Jones, D.R.; Frye, R.A.; Mayo, M.W. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004, 23, 2369-2380.
73. Wu, M.; Xu, L.G.; Zhai, Z.; Shu, H.B. SINK is a p65-interacting negative regulator of NF-kappaB-dependent transcription. J. Biol. Chem. 2003, 278, 27072-27079.
74. Šošić, D.; Richardson, J.A.; Yu, K.; Ornitz, D.M.; Olson, E.N. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity. Cell 2003, 112, 169-180.
75. Yang, J.P.; Hori, M.; Sanda, T.; Okamoto, T. Identification of a novel inhibitor of nuclear factor-kappaB, RelA-associated inhibitor. J. Biol. Chem. 1999, 274, 15662-15670.
76. Sun, S.C.; Ganchi, P.A.; Ballard, D.W.; Greene, W.C. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science 1993, 259, 1912-1915.
77. Saccani, S.; Marazzi, I.; Beg, A.A.; Natoli, G. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response. J. Exp. Med. 2004, 200, 107-113.
78. Tanaka, T.; Grusby, M.J.; Kaisho, T. PDLIM2-mediated termination of transcription factor NF-kappaB activation by intranuclear sequestration and degradation of the p65 subunit. Nat. Immunol. 2007, 8, 584-591.
79. Fu, J.; Yan, P.; Li, S.; Qu, Z.; Xiao, G. Molecular determinants of PDLIM2 in suppressing HTLV-I Tax-mediated tumorigenesis. Oncogene 2010, 29, 6499-6507.
80. Watanabe, M.; Ohsuqi, T.; Shoda, M.; Ishida, T.; Aizawa, S.; Maruyama-Nagai, M.; Utsunomiya, A.; Koga, S.; Yamada, Y.; Kamihira, S. et al. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood 2005, 106, 2462-2471.
81. Ballard, D.W.; Böhnlein, E.; Lowenthal, J.W.; Wano, Y.; Franza, B.R.; Greene, W.C. HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene. Science 1988, 241, 1652-1655.
82. Böhnlein, E.; Siekevitz, M.; Ballard, D.W.; Lowenthal, J.W.; Rimsky, L.; Bogérd, H.; Hoffman, J.; Wano, Y.; Franza, B.R.; Greene, W.C. Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins. J. Virol. 1989, 63, 1578-1586.
83. Leung, K.; Nabel, G.L. HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor. Nature 1988, 333, 776-778.
84. Ruben, S.; Poteat, H.; Tan, T.H.; Kawakami, K.; Roeder, R.; Haseltine, W.; Rosen, C.A. Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I tax gene product. Science 1988, 241, 89-92.
85. Chu, Z.L.; Shin, Y.A.; Yang, J.M.; DiDonato, J.A.; Ballard, D.W. IKKgamma mediates the interaction of cellular IkappaB kinases with the tax transforming protein of human T cell leukemia virus type 1. J. Biol. Chem. 1999, 274, 15297-15300.
86. Harhaj, E.W.; Sun, S.C. IKKgamma serves as a docking subunit of the IkappaB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein. J. Biol. Chem. 1999, 274, 22911-22914.
87. Jin, D.Y.; Giordano, V.; Kibler, K.V.; Nakano, H.; Jeang, K.T. Role of adapter function in oncoprotein-mediated activation of NF-kappaB. Human T-cell leukemia virus type I Tax interacts directly with IkappaB kinase gamma. J. Biol. Chem. 1999, 274, 17402-17405.
88. Xiao, G.; Harhaj, E.W.; Sun, S.C. Domain-specific interaction with the I kappa B kinase (IKK)regulatory subunit IKK gamma is an essential step in tax-mediated activation of IKK. J. Biol. Chem. 2000, 275, 34060-34067.
89. O'Mahony, A.M.; Montanp, M.; Van Beneden, K.; Chen, L.F.; Greene, W.C. Human T-cell lymphotropic virus type 1 tax induction of biologically Active NF-kappaB requires IkappaB kinase-1-mediated phosphorylation of RelA/p65. J. Biol. Chem. 2004, 279, 18137-18145.
90. Semmes, O.J.; Jeang, K.T. Localization of human T-cell leukemia virus type 1 tax to subnuclear compartments that overlap with interchromatin speckles. J. Virol. 1996, 70, 6347-6357.
91. Bex, F.; McDowall, A.; Burny, A.; Gaynor, R. The human T-cell leukemia virus type 1 transactivator protein Tax colocalizes in unique nuclear structures with NF-kappaB proteins. J. Virol. 1997, 71, 3484-3497.
92. Jin, D.Y.; Jeang, K.T. HTLV-I Tax self-association in optimal trans-activation function. Nucleic Acids Res. 1997, 25, 379-387.
93. Tie, F.; Adya, N.; Greene, W.C.; Giam, C.Z. Interaction of the human T-lymphotropic virus type 1 Tax dimer with CREB and the viral 21-base-pair repeat. J. Virol. 1996, 70, 8368-8374.
94. Xiao, G.; Sun, S.C. Activation of IKKalpha and IKKbeta through their fusion with HTLV-I tax protein. Oncogene 2000, 19, 5198-5203.
95. Yu, Q.; Minoda, Y.; Yoshida, R.; Yoshida, H.; Iha, H.; Kobayashi, T.; Yoshimura, A.; Takaesu, G. HTLV-1 Tax-mediated TAK1 activation involves TAB2 adapter protein. Biochem. Biophys. Res. Commun. 2008, 365, 189-194.
96. Uhlik, M., Good, L.; Xiao, G.; Harhaj, E.W.; Zandi, E.; Karin, M.; Sun, S.C. NF-kappaB-inducing kinase and IkappaB kinase participate in human T-cell leukemia virus I Tax-mediated NF-kappaB activation. J. Biol. Chem. 1998, 273, 21132-21136.
97. Yin, M.J.; Christerson, L.B.; Yamamoto, Y.; Kwak, Y.T.; Xu, S.; Mercurio, F.; Barbosa, M.; Cobb, M.H.; Gaynor, R.B. HTLV-I Tax protein binds to MEKK1 to stimulate IkappaB kinase activity and NF-kappaB activation. Cell 1998, 93, 875-884.
98. Babu, G.; Waterfield, M.; Chang, M.; Wu, X.; Sun, S.C. Deregulated activation of oncoprotein kinase Tpl2/Cot in HTLV-I-transformed T cells. J. Biol. Chem. 2006, 281, 14041-14047.
99. Suzuki, S.; Singhirunnusorn, P.; Mori, A.; Yamaoka, S.; Kitajima, I.; Saiki, I.; Sakurai, H. Constitutive activation of TAK1 by HTLV-1 tax-dependent overexpression of TAB2 induces activation of JNK-ATF2 but not IKK-NF-kappaB. J. Biol. Chem. 2007, 282, 25177-25181.
100. Gohda, J.; Irisawa, M.; Tanaka, Y.; Sato, S.; Ohtani, K.; Fujisawa, J.; Inoue, J. HTLV-1 Tax-induced NFkappaB activation is independent of Lys-63-linked-type polyubiquitination. Biochem. Biophys. Res. Commun. 2007, 357, 225-230.
101. Suzuki, S.; Zhou, Y.; Refaat, A.; Takasaki, I.; Koizumi, K.; Yamaoka, S.; Tabuchi, Y.; Saiki, I.; Sakurai, H. Human T cell lymphotropic virus 1 manipulates interferon regulatory signals by controlling the TAK1-IRF3 and IRF4 pathways. J. Biol. Chem. 2010, 285, 4441-4446.
102. Kfoury, Y.; Nasr, R.; Favre-Bonvin, A.; El-Sabban, M.; Renault, N.; Giron, M.L.; Setterblad, N.; Hajj, H.E.; Chiari, E.; Mikati, A.G. et al. Ubiquitylated Tax targets and binds the IKK signalosome at the centrosome. Oncogene 2008, 27, 1665-1676.
103. Harhaj, N.S.; Sun, S.C.; Harhaj, E.W. Activation of NF-kappa B by the human T cell leukemia virus type I Tax oncoprotein is associated with ubiquitin-dependent relocalization of I kappa B kinase. J. Biol. Chem. 2007, 282, 4185-4192.
104. Journo, C.; Filipe, J.; About, F.; Chevalier, S.A.; Afonso, P.V.; Brady, J.N.; Flynn, D.; Tangy, F.; Israël, A.; Vidalain, P.O. et al. NRP/Optineurin Cooperates with TAX1BP1 to potentiate the activation of NF-kappaB by human T-lymphotropic virus type 1 tax protein. PLoS Pathog. 2009, 5, e1000521.
105. Avesani, F.; Romanelli, M.G.; Turci, M.; Di Gennaro, G.; Sampaio, C.; Bidoia, C.; Bertazzoni, U.; Bex, F. Association of HTLV Tax proteins with TAK1-binding protein 2 and RelA in calreticulin-containing cytoplasmic structures participates in Tax-mediated NF-κB activation. Virology 2010, 408, 39-48.
106. Huang, J.; Ren, T.; Guan, H.; Jiang, Y.; Cheng, H. HTLV-1 Tax is a critical lipid raft modulator that hijacks IkappaB kinases to the microdomains for persistent activation of NF-kappaB. J. Biol. Chem. 2009, 284, 6208-6217.
107. Lamsoul, I.; Lodewick, J.; Lebrun, S.; Brasseur, R.; Burny, A.; Gaynor, R.B.; Bex, F. Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-kappaB activation by the human T-cell leukemia virus tax oncoprotein. Mol. Cell Biol. 2005, 25, 10391-10406.
108. Nasr, R.; Chiari, E.; El-Sabban, M.; Mahieux, R.; Kfoury, Y.; Abdulhay, M.; Yazbeck, V.; Hermine, O.; de Thé, H.; Pique, C.; Bazarbachi, A. Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-kappaB activation. Blood 2006, 107, 4021-4029.
109. Shembade, N.; Harhaj, N.S.; Yamamoto, M.; Akira, S.; Harhaj, E.W. The human T-cell leukemia virus type 1 Tax oncoprotein requires the ubiquitin-conjugating enzyme Ubc13 for NF-kappaB activation. J. Virol. 2003, 81, 13735-13742.
110. Kfoury, Y.; Setterblad, N.; El-Sabban, M.; Zamborlini, A.; Dassouki, Z.; El Hajj, H.; Hermine, O.; Pique, C.; de Thé, H.; Saïb, A.; Bazarbachi, A. Tax ubiquitylation and SUMOylation control the dynamic shuttling of Tax and NEMO between Ubc9 nuclear bodies and the centrosome. Blood 2011, 117, 190-199.
111. Miyamoto, S. Nuclear initiated NF-kappa B signaling: NEMO and ATM take center stage. Cell Res. 2011, 21, 116-130.
112. Huang, T.T.; Wuerzberger-Davis, S.M.; Wu, Z.H.; Miyamoto, S. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 2003, 115, 565-576.
113. Verma, U.N.; Yamamoto, Y.; Prajapati, S.; Gaynor, R.B. Nuclear role of I kappa B Kinase-gamma/NF-kappa B essential modulator (IKK gamma/NEMO) in NF-kappa B-dependent gene expression. J. Biol. Chem. 2004, 279, 3509-3515.
114. Bex, F.; Murphy, K.; Wattiez, R.; Burny, A.; Gaynor, R.B. Phosphorylation of the human T-cell leukemia virus type 1 transactivator tax on adjacent serine residues is critical for tax activation. J. Virol. 1999, 73, 738-745.
115. Lodewick, J.; Lamsoul, I.; Polania, A.; Lebrun, S.; Burny, A.; Ratner, L.; Bex, F. Acetylation of the human T-cell leukemia virus type 1 Tax oncoprotein by p300 promotes activation of the NF-kappaB pathway. Virology 2009, 386, 68-78.
116. Durkin, S.S.; Ward, M.D.; Fryrear, K.A.; Semmes, O.J. Site-specific phosphorylation differentiates active from inactive forms of the human T-cell leukemia virus type 1 Tax oncoprotein. J. Biol. Chem. 2006, 281, 31705-31712.
117. Peloponese, J.M., Jr.; Yasunaga, J.; Kinjo, T.; Watashi, K.; Jeang, K.T. Peptidylproline cis-trans-isomerase Pin1 interacts with human T-cell leukemia virus type 1 tax and modulates its activation of NF-kappaB. J. Virol. 2009, 83, 3238-3248.
118. Jeong, S.J.; Rya, A.; Yamamoto, N. The prolyl isomerase Pin1 stabilizes the human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein and promotes malignant transformation. Biochem. Biophys. Res. Commun. 2009, 381, 294-299.
119. Fan, G.; Fan, Y.; Gupta, N.; Matsuura, I.; Liu, F.; Zhou, X.Z.; Lu, K.P.; Gélinas, C. Peptidyl-prolyl isomerase Pin1 markedly enhances the oncogenic activity of the rel proteins in the nuclear factor-kappaB family. Cancer Res. 2009, 69, 4589-4597.
120. Xiao, G.; Cvijic, M.E.; Fong, A.; Harhaj, E.W.; Uhlik, M.T.; Waterfield, M.; Sun, S.C. Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: Evidence for the involvement of IKKalpha. EMBO J. 2001, 20, 6805-6815.
121. Harhaj, E.W.; Good, L.; Xiao, G.; Uhlik, M.; Cvijic, M.E.; Rivera-Walsh, I.; Sun, S.C. Somatic mutagenesis studies of NF-kappa B signaling in human T cells: evidence for an essential role of IKK gamma in NF-kappa B activation by T-cell costimulatory signals and HTLV-I Tax protein. Oncogene 2000, 19, 1448-1456.
122. Yamaoka, S.; Courtois, G.; Bessia, C.; Whiteside, S.T.; Weil, R.; Agou, F.; Kirk, H.E.; Kay, R.J.; Israël, A. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 1998, 93, 1231-1240.
123. Qu, Z.; Qing, G.; Rabson, A.B.; Xiao, G. Tax deregulation of NF-kappaB2 p100 processing involves both beta-TrCP-dependent and -independent mechanisms. J. Biol. Chem. 2004, 279, 44563-44572.
124. Furukawa, Y.; Kubota, R.; Tara, M.; Izumo, S.; Osame, M. Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia. Blood 2001, 97, 987-993.
125. Furukawa, Y.; Osame, M.; Kubota, R.; Tara, M.; Yoshida, M. Human T-cell leukemia virus type-1 (HTLV-1) Tax is expressed at the same level in infected cells of HTLV-1-associated myelopathy or tropical spastic paraparesis patients as in asymptomatic carriers but at a lower level in adult T-cell leukemia cells. Blood 1995, 85, 1865-1870.
126. Koiwa, T.; Hamano-Usami, A.; Ishida, T.; Okayama, A.; Yamaguchi, K.; Kamihira, S.; Watanabe, T. 5'-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo. J. Virol. 2001, 76, 9389-9397.
127. Takeda, S.; Maeda, M.; Morikawa, S.; Taniguchi, Y.; Yasunaga, J.; Nosaka, K.; Tanaka, Y.; Matsuoka, M. Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int. J. Cancer 2004, 109, 559-567.
128. Taniguchi, Y.; Nosaka, K.; Yasunaga, J.; Maeda, M.; Mueller, N.; Okayama, A.; Matsuoka, M. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms. Retrovirology 2005, 2, 64.
129. Tamiya, S.; Matsuoka, M.; Etoh, K.; Watanabe, T.; Kamihira, S.; Yamaguchi, K.; Takatsuki, K. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. Blood 1996, 88, 3065-3073.
130. Hironaka, N.; Mochida, K.; Mori, N.; Maeda, M.; Yamamoto, N.; Yamaoka, S. Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells. Neoplasia 2004, 6, 266-278.
131. Mori, N.; Fujii, M.; Ikeda, S.; Yamada, Y.; Tomonaga, M.; Ballard, D.W.; Yamamoto, N. Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. Blood 1999, 93, 2360-2368.
132. Yan, P.; Qing, G.; Qu, Z.; Wu, C.C.; Rabson, A.B; Xiao, G. Targeting autophagic regulation of NFkappaB in HTLV-I transformed cells by geldanamycin: Implications for therapeutic interventions. Autophagy 2007, 3, 600-603.
133. Jang, I.K.; Gu, H. Negative regulation of TCR signaling and T-cell activation by selective protein degradation. Curr. Opin. Immunol. 2003, 15, 315-320.
134. Gupta, N.; Delrow, J.; Drawid, A.; Sengupta, A.M.; Fan, G.; Gélinas, C. Repression of B-cell linker (BLNK) and B-cell adaptor for phosphoinositide 3-kinase (BCAP) is important for lymphocyte transformation by rel proteins. Cancer Res. 2008, 68, 808-814.
135. Harhaj, E.W.; Good, L.; Xiao, G.; Sun, S.C. Gene expression profiles in HTLV-I-immortalized T cells: deregulated expression of genes involved in apoptosis regulation. Oncogene 1999, 18, 1341-1349.
136. Koga, Y.; Oh-Hori, N.; Sato, H.; Yamamoto, N.; Kimura, G.; Nomoto, K. Absence of transcription of lck (lymphocyte specific protein tyrosine kinase) message in IL-2-independent, HTLV-I-transformed T cell lines. J. Immunol. 1989, 142, 4493-4499.
137. Yssel, H.; de Waal Malefyt, R.; Duc Dodon, M.D.; Blanchard, D.; Gazzolo, L.; de Vries, J.E.; Spits, H. Human T cell leukemia/lymphoma virus type I infection of a CD4+ proliferative/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells. J. Immunol. 1989, 142, 2279-2289.
138. de Waal Malefyt, R.; Yssel, H.; Spits, H.; de Vries, J.E.; Sancho, J.; Terhorst, C.; Alarcon, B. Human T cell leukemia virus type I prevents cell surface expression of the T cell receptor through down-regulation of the CD3-gamma, -delta, -epsilon, and -zeta genes. J. Immunol. 1990, 145, 2297-2303.
139. Weil, R.; Levraud, J.; Dodon, M.D.; Bessia, C.; Hazan, U.; Kourilsky, P.; Israël, A. Altered expression of tyrosine kinases of the Src and Syk families in human T-cell leukemia virus type 1-infected T-cell lines. J. Virol. 1999, 73, 3709-3717.
140. Harhaj, E.W,; Harhaj, N.S.; Grant, C.; Mostoller, K.; Alefantis, T.; Sun, S.C.; Wigdahl, B. Human T cell leukemia virus type I Tax activates CD40 gene expression via the NF-kappaB pathway. Virology 2005, 333, 145-158.
141. Higuchi, M.; Matsuda, T.; Mori, N.; Yamada, Y.; Horie, R.; Watanabe, T.; Takahashi, M.; Oie, M.; Fujii, M. Elevated expression of CD30 in adult T-cell leukemia cell lines: possible role in constitutive NF-kappaB activation. Retrovirology 2005, 2, 29.
142. Cowan, E.P.; Alexander, R.K.; Daniel, S.; Kashanchi, F.; Brady, J.N. Induction of tumor necrosis factor alpha in human neuronal cells by extracellular human T-cell lymphotropic virus type 1 Tax. J. Virol. 1997, 71, 6982-6989.
143. Kim, Y.M.; Sharma, N.; Nyborg, J.K. The proto-oncogene Bcl3, induced by Tax, represses Tax-mediated transcription via p300 displacement from the human T-cell leukemia virus type 1 promoter. J. Virol. 2008, 82, 11939-11947.
144. Coope, H.J.; Atkinson, P.; Huhse, B.; Belich, M.; Janzen, J.; Holman, M.J.; Klaus, G.G.; Johnston, L.H.; Ley, S.C. CD40 regulates the processing of NF-kappaB2 p100 to p52. EMBO J. 2002, 21, 5375-5385.
145. Wright, C.W.; Rumble, J.M.; Duckett, C.S. CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells. J. Biol. Chem. 2007, 282, s10252-s10262.
146. Horie, R.; Higashihara, M.; Watanabe, T. Hodgkin's lymphoma and CD30 signal transduction. Int. J. Hematol. 2003, 77, 37-47.
147. Marriott, S.J.; Semmes, O.J. Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response. Oncogene 2005, 24, 5986-5995.
148. Chlichlia, K.; Khazaie, K. HTLV-1 Tax: Linking transformation, DNA damage and apoptotic T-cell death. Chem. Biol. Interact. 2010, 188, 359-365.
149. Isogawa, M.; Higuchi, M.; Takahashi, M.; Oie, M.; Mori, N.; Tanaka, Y.; Aoyagi, Y.; Fujii, M. Rearranged NF-kappa B2 gene in an adult T-cell leukemia cell line. Cancer Sci. 2008, 99, 792-798.
150. Saitoh, Y.; Yamamoto, N.; Dewan, M.Z.; Sugimoto, H.; Martinez Bruyn, V.J.; Iwasaki, Y.; Matsubara, K.; Qi, X.; Saitoh, T.; Imoto, I. et al. Overexpressed NF-kappaB-inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed-Sternberg cells. Blood 2008, 111, 5118-5129.
151. Yamamoto, M.; Ito, T.; Shimizu, T.; Ishida, T.; Semba, K.; Watanabe, S.; Yamaguchi, N.; Inoue, J., Epigenetic alteration of the NF-kappaB-inducing kinase (NIK) gene is involved in enhanced NIK expression in basal-like breast cancer. Cancer Sci. 2010, 101, 2391-2397.
152. Qing, G.; Qu, Z.; Xiao, G. Endoproteolytic processing of C-terminally truncated NF-kappaB2 precursors at kappaB-containing promoters. Proc. Natl. Acad Sci. U. S. A. 2007, 104, 5324-5329.
153. Qing, G.; Xiao, G. Essential role of IkappaB kinase alpha in the constitutive processing of NF-kappaB2 p100. J. Biol. Chem. 2005, 280, 9765-9768.
154. Watanabe, M.; Muramatsu, M.; Hirai, H.; Suzuki, T.; Fujisawa, J.; Yoshida, M.; Arai, K.; Arai, N. HTLV-I encoded Tax in association with NF-kappa B precursor p105 enhances nuclear localization of NF-kappa B p50 and p65 in transfected cells. Oncogene 1992, 8, 2949-2958.
155. McKinsey, T.A.; Brockman, J.A.; Scherer, D.C.; Al-Murrani, S.W.; Green, P.L.; Ballard, D.W. Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB. Mol. Cell Biol. 1996, 16, 2083-2090.
156. Good, L.; Sun, S.C. Persistent activation of NF-kappa B/Rel by human T-cell leukemia virus type 1 tax involves degradation of I kappa B beta. J. Virol. 1996, 70, 2730-2735.
157. Maggirwar, S.B.; Harhaj, E.W.; Sun, S.C. Activation of NF-kappa B/Rel by Tax involves degradation of I kappa B alpha and is blocked by a proteasome inhibitor. Oncogene 1995, 11, 993-998.
158. Sun, S.C.; Xiao, G. Deregulation of NF-kappaB and its upstream kinases in cancer. Cancer Metastasis Rev. 2003, 22, 405-422.
159. Hirai, H.; Fujisawa, J.; Suzuki, T.; Ueda, K.; Muramatsu, M.; Tsuboi, A.; Arai, N.; Yoshida, M., Transcriptional activator Tax of HTLV-1 binds to the NF-kappa B precursor p105. Oncogene 1992, 7, 1737-1742.
160. Suzuki, T.; Hirai, H.; Fujisawa, J.; Fujita, T.; Yoshida, M., A trans-activator Tax of human T-cell leukemia virus type 1 binds to NF-kappa B p50 and serum response factor (SRF) and associates with enhancer DNAs of the NF-kappa B site and CArG box. Oncogene 1993, 8, 2391-2397.
161. Suzuki, T.; Hirai, H.; Yoshida, M. Tax protein of HTLV-1 interacts with the Rel homology domain of NF-kappa B p65 and c-Rel proteins bound to the NF-kappa B binding site and activates transcription. Oncogene 1994, 9, 3099-3105.
162. Murakami, T.; Hirai, H.; Suzuki, T.; Fujisawa, J.; Yoshida, M. HTLV-1 Tax enhances NF-kappa B2 expression and binds to the products p52 and p100, but does not suppress the inhibitory function of p100. Virology 1995, 206, 1066-1074.
163. Suzuki, T.; Hirai, H.; Murakami, T.; Yoshida, M. Tax protein of HTLV-1 destabilizes the complexes of NF-kappa B and I kappa B-alpha and induces nuclear translocation of NF-kappa B for transcriptional activation. Oncogene 1995, 10, 1199-1207.
164. Petropoulos, L.; Lin, R.; Hiscott, J. Human T cell leukemia virus type 1 tax protein increases NF-kappa B dimer formation and antagonizes the inhibitory activity of the I kappa B alpha regulatory protein. Virology 1996, 225, 52-64.
165. Beraud, C.; Sun, S.C.; Ganchi, P.; Ballard, D.W.; Greene, W.C. Human T-cell leukemia virus type I Tax associates with and is negatively regulated by the NF-kappa B2 p100 gene product: implications for viral latency. Mol. Cell Biol. 1994, 14, 1374-1382.
166. Lacoste, J.; Lanoix, J.; Pepin, N.; Hiscott, J. Interactions between HTLV-I Tax and NF-kappa B/Rel proteins in T cells. Leukemia 1994, 8, S71-S76.
167. Lanoix, J.; Lacoste, J.; Pepin, N.; Rice, N.; Hiscott, J. Overproduction of NFKB2 (lyt-10) and c-Rel: a mechanism for HTLV-I Tax-mediated trans-activation via the NF-kappa B signalling pathway. Oncogene 1994, 9, 841-852.
168. Yan, P.; Fu, J.; Qu, Z.; Li, S.; Tanaka, T.; Grusby, M.J.; Xiao, G., PDLIM2 suppresses human T-cell leukemia virus type I Tax-mediated tumorigenesis by targeting Tax into the nuclear matrix for proteasomal degradation. Blood 2009, 113, 4370-4380.
169. Arima, N.; Molitor, J.A.; Smith, M.R.; Kim, J.H.; Daitoku, Y.; Greene, W.C. Human T-cell leukemia virus type I Tax induces expression of the Rel-related family of kappa B enhancer-binding proteins: evidence for a pretranslational component of regulation. J. Virol. 1991, 65, 6892-6899.
170. Inoue, M.; Matsuoka, M.; Yamaguchi, K.; Takatsuki, K.; Yoshida, M. Characterization of mRNA expression of IkappaB alpha and NF-kappaB subfamilies in primary adult T-cell leukemia cells. Jpn. J. Cancer Res. 1998, 89, 53-59.
171. Li, C.C.; Ruscetti, F.W.; Rice, N.R.; Chen, E.; Yang, N.S.; Mikovits, J.; Longo, D.L. Differential expression of Rel family members in human T-cell leukemia virus type I-infected cells: transcriptional activation of c-rel by Tax protein. J. Virol. 1993, 67, 4205-4213.
172. Fu, J.; Qu, Z.; Yan, P.; Ishikawa, C.; Aqeilan, R.; Rabson, A.B.; Xiao, G. The tumor suppressor gene wwox links the canonical and non-canonical NF-kappaB pathways in HTLV-I Tax-mediated tumorigenesis. Blood 2011, 117, 1652-1661.
173. Jeong, S.J.; Pise-Masison, C.A.; Radonovich, M.F.; Park, H.U.; Brady, J.N. Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells. Oncogene 2005, 24, 6719-6728.
174. Fukuda, R.I.; Tsuchiya, K.; Suzuki, K.; Itoh, K; Fujita, J.; Utsunomiya, A.; Tsuji, T. Human T-cell leukemia virus type I tax down-regulates the expression of phosphatidylinositol 3,4,5-trisphosphate inositol phosphatases via the NF-kappaB pathway. J. Biol. Chem. 2009, 284, 2680-2689.
175. Köntgen, F.; Grumont, R.J.; Strasser, A.; Metcalf, D.; Li, R.; Tarlinton, D.; Gerondakis, S. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 1995, 9, 1965-1977.
176. Liou, H.C.; Jin, Z.; Tumang, J.; Andjelic, S.; Smith, K.A.; Liou, M.L. c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function. Int. Immunol. 1999, 11, 361-371.
177. Ishikawa, C.; Nakachi, S.; Senba, M.; Sugai, M.; Mori, N. Activation of AID by human T-cell leukemia virus Tax oncoprotein and the possible role of its constitutive expression in ATL genesis. Carcinogenesis 2011, 32, 110-119.
178. Smith, M.R.; Greene, W.C. Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes. Genes Dev. 1990, 4, 1875-1885.
179. Semmes, O.J.; Jeang, K.T. Mutational analysis of human T-cell leukemia virus type I Tax: regions necessary for function determined with 47 mutant proteins. J. Virol. 1992, 66, 7183-7192.
180. Yamaoka, S.; Inoue, H.; Sakurai, M.; Sugiyama, T.; Hazama, M.; Yamada, T.; Hatanaka, M. Constitutive activation of NF-kappa B is essential for transformation of rat fibroblasts by the human T-cell leukemia virus type I Tax protein. EMBO J. 1996, 15, 873-887.
181. Smith, M.R.; Greene, W.C. Type I human T cell leukemia virus tax protein transforms rat fibroblasts through the cyclic adenosine monophosphate response element binding protein/activating transcription factor pathway. J. Clin. Invest. 1991, 88, 1038-1042.
182. Matsumoto, K.; Shibata, H.; Fujisawa, J.I.; Inoue, H.; Hakura, A.; Tsukahara, T.; Fujii, M. Human T-cell leukemia virus type 1 Tax protein transforms rat fibroblasts via two distinct pathways. J. Virol. 1997, 71, 4445-4451.
183. Rosin, O.; Koch, C.; Schmitt, I.; Semmes, O.J.; Jeang, K.T.; Grassmann, R. A human T-cell leukemia virus Tax variant incapable of activating NF-kappaB retains its immortalizing potential for primary T-lymphocytes. J. Biol. Chem. 1998, 271, 6698-6703.
184. Iwanaga, Y.; Tsukahara, T.; Ohashi, T.; Tanaka, Y.; Arai, M.; Nakamura, M.; Ohtani, K.; Koya, Y.; Kannagi, M.; Yamamoto, N.; Fujii, M. Human T-cell leukemia virus type 1 tax protein abrogates interleukin-2 dependence in a mouse T-cell line. J. Virol. 1999, 73, 1271-1277.
185. Akagi, T.; Ono, H.; Nyunoya, H.; Shimotohno, K. Characterization of peripheral blood T-lymphocytes transduced with HTLV-I Tax mutants with different trans-activating phenotypes. Oncogene 1997, 14, 2071-2078.
186. Robek, M.D.; Ratner, L. Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J. Virol. 1999, 73, 4856-4865.
187. Ross, T.M.; Narayan, M.; Fang, Z.Y.; Minella, A.C.; Green, P.L. Human T-cell leukemia virus type 2 tax mutants that selectively abrogate NFkappaB or CREB/ATF activation fail to transform primary human T cells. J. Virol. 2000, 74, 2655-2662.
188. Kitajima, I.; Shinohara, T.; Bilakovics, J.; Brown, D.A.; Xu, X.; Nerenberg, M. Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-kappa B. Science 1992, 258, 1792-1795.
189. Mori, N.; Yamada, Y.; Ikeda, S.; Yamasaki, Y.; Tsukasaki, K.; Tanaka, Y.; Tomonaga, M.; Yamamoto, N.; Fujii, M. Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood 2002, 100, 1828-1834.
190. Nasr, R.; El-Sabban, M.E.; Karam, J.A.; Dbaibo, G.; Kfoury, Y.; Arnulf, B.; Lepelletier, Y.; Bex, F.; de Thé, H.; Hermine, O.; Bazarbachi, A. Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma. Oncogene 2005, 24, 419-430.
191. Satou, Y.; Nosaka, K.; Koya, Y.; Yasunaga, J.I.; Toyokuni, S.; Matsuoka, M. Proteasome inhibitor, bortezomib, potently inhibits the growth of adult T-cell leukemia cells both in vivo and in vitro. Leukemia 2004, 18, 1357-1363.
192. Sanda, T.; Asamitsu, K.; Ogura, H.; Iida, S.; Utsunomiya, A.; Ueda, R.; Okamoto, T. Induction of cell death in adult T-cell leukemia cells by a novel IkappaB kinase inhibitor. Leukemia 2006, 20, 590-598.
193. Mitra-Kaushik, S.; Harding J.C.; Hess, J.L.; Ratner, L. Effects of the proteasome inhibitor PS-341 on tumor growth in HTLV-1 Tax transgenic mice and Tax tumor transplants. Blood 2004, 104, 802-809.
194. Kwon, H.; Ogle, L.; Benitez, B.; Bohuslav, J.; Montano, M.; Felsher, D.W.; Greene, W.C. Lethal cutaneous disease in transgenic mice conditionally expressing type I human T cell leukemia virus Tax. J. Biol. Chem. 2005, 280, 35713-35722.
195. Iwanaga, R.; Ozono, E.; Fujisawa, J.; Ikeda, M.A.; Okamura, N.; Huang, Y.; Ohtani, K. Activation of the cyclin D2 and cdk6 genes through NF-kappaB is critical for cell-cycle progression induced by HTLV-I Tax. Oncogene 2008, 27, 5635-5642.
196. Higuchi, M.; Tsubata, C.; Kondo, R.; Yoshida, S.; Takahashi, M.; Oie, M.; Tanaka, Y.; Mahieux, R.; Matsuoka, M.; Fujii, M. Cooperation of NF-kappaB2/p100 activation and the PDZ domain binding motif signal in human T-cell leukemia virus type 1 (HTLV-1) Tax1 but not HTLV-2 Tax2 is crucial for interleukin-2-independent growth transformation of a T-cell line. J. Virol. 2007, 81, 11900-11907.
197. Chen, J.; Petrus, M.; Bryant, B.R.; Phuc Nguyen, V.; Stamer, M.; Goldman, C.K.; Bamford, R.; Morris, J.C.; Janik, J.E.; Waldmann, T.A. Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism. Blood 2008, 111, 5163-5172.
198. Jin, Z.; Nagakubo, D.; Shirakawa, A.K.; Nakayama, T.; Shigeta, A.; Hieshima, K.; Yamada, Y.; Yoshie, O. CXCR7 is inducible by HTLV-1 Tax and promotes growth and survival of HTLV-1-infected T cells. Int. J. Cancer 2009, 125, 2229-2235.
199. Larousserie, F.; Bardel E.; Pflanz, S.; Arnulf, B.; Lome-Maldonado, C.; Hermine, O.; Brégeaud, L.; Perennec, M.; Brousse, N.; Kastelein, R.; Devergne, O. Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells. Am. J. Pathol. 2005, 166, 1217-1228.
200. Li-Weber, M.; Giaisi, M.; Chlichlia, K.; Khazaie, K.; Krammer, P.H. Human T cell leukemia virus type I Tax enhances IL-4 gene expression in T cells. Eur. J. Immunol. 2001, 31, 2623-2632.
201. Mizuguchi, M.; Asao, H.; Hara, T.; Higuchi, M.; Fujii, M.; Nakamura, M. Transcriptional activation of the interleukin-21 gene and its receptor gene by human T-cell leukemia virus type 1 Tax in human T-cells. J. Biol. Chem. 2009, 284, 25501-25511.
202. Mori, N.; Fujii, M.; Cheng, G.; Ikeda, S.; Yamasaki, Y.; Yamada, Y.; Tomonaga, M.; Yamamoto, N. Human T-cell leukemia virus type I tax protein induces the expression of anti-apoptotic gene Bcl-xL in human T-cells through nuclear factor-kappaB and c-AMP responsive element binding protein pathways. Virus Genes 2001, 22, 279-287.
203. Pichler, K.; Schneider, G.; Grassmann, R. MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes. Retrovirology 2008, 5, 100.
204. Tomita, M.; Tanaka, Y.; Mori, N. MicroRNA miR-146a is induced by HTLV-1 tax and increases the growth of HTLV-1-infected T-cells. Int. J. Cancer 2009, doi:10.1002/ijc.25115.
205. Tsukahara, T.; Kannagi, M., Ohashi, T.; Kato, H.; Arai, M.; Nunez, G.; Iwanaga, Y.; Yamamoto, N.; Ohtani, K.; Nakamura, M.; Fujii, M. Induction of Bcl-x(L) expression by human T-cell leukemia virus type 1 Tax through NF-kappaB in apoptosis-resistant T-cell transfectants with Tax. J. Virol. 1999, 73, 7981-7987.
206. Akita, K.; Kawata, S.; Shimotohno, K. p21WAF1 modulates NF-kappaB signaling and induces anti-apoptotic protein Bcl-2 in Tax-expressing rat fibroblast. Virology 2005, 332, 249-257.
207. Silbermann, K.; Schneider, G.; Grassmann, R. Stimulation of interleukin-13 expression by human T-cell leukemia virus type 1 oncoprotein Tax via a dually active promoter element responsive to NF-kappaB and NFAT. J. Gen. Virol. 2008, 89, 2788-2798.
208. Mariner, J.M.; Lantz, V.; Waldmann, T.A.; Azimi, N. Human T cell lymphotropic virus type I Tax activates IL-15R alpha gene expression through an NF-kappa B site. J. Immunol. 2001, 166, 2602-2609.
209. Mori, N.; Mukaida, N.; Ballard, D.W.; Matsushima, K.; Yamamoto, N. Human T-cell leukemia virus type I Tax transactivates human interleukin 8 gene through acting concurrently on AP-1 and nuclear factor-kappaB-like sites. Cancer Res. 1998, 58, 3993-4000.
210. Mori, N.; Ueda, A.; Ikeda, S.; Yamasaki, Y.; Yamada, Y.; Tomonaga, M.; Morikawa, S.; Geleziunas, R.; Yoshimura, T. Yamamoto N., Human T-cell leukemia virus type I tax activates transcription of the human monocyte chemoattractant protein-1 gene through two nuclear factor-kappaB sites. Cancer Res. 2000, 60, 4939-4945.
211. Pichler, K.; Kattan, T.; Gentzsch, J.; Kress, A.K.; Taylor, G.P.; Bangham, C.R.; Grassmann, R. Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients' T cells by the viral Tax oncoprotein. Blood 2008, 111, 4741-4751.
212. Pankow, R.; Dürkop, H.; Latza, U.; Krause, H.; Kunzendorf, U.; Pohl, T.; Bulfone-Paus, S. The HTLV-I tax protein transcriptionally modulates OX40 antigen expression. J. Immunol. 2000, 165, 263-270.
213. Ohtani, K.; Tsujimoto, A.; Tsukahara, T.; Numata, N.; Miura, S.; Sugamura, K.; Nakamura, M. Molecular mechanisms of promoter regulation of the gp34 gene that is trans-activated by an oncoprotein Tax of human T cell leukemia virus type I. J. Biol. Chem. 1998, 273, 14119-14129.
214. Mori, N.; Fujii, M.; Hinz, M.; Nakayama, K.; Yamada, Y.; Ikeda, S.; Yamasaki, Y.; Kashanchi, F.; Tanaka, Y.; Tomonaga, M.; Yamamoto, N. Activation of cyclin D1 and D2 promoters by human T-cell leukemia virus type I tax protein is associated with IL-2-independent growth of T cells. Int. J. Cancer 2002, 99, 378-385.
215. Wäldele, K.; Silbermann, K.; Schneider, G.; Ruckes, T.; Cullen, B.R.; Grassmann, R. Requirement of the human T-cell leukemia virus (HTLV-1) tax-stimulated HIAP-1 gene for the survival of transformed lymphocytes. Blood 2006, 107, 4491-4499.
216. Mori, N.; Shirakawa, F.; Shimizu, H.; Murakami, S.; Oda, S.; Yamamoto, K.; Eto, S. Transcriptional regulation of the human interleukin-6 gene promoter in human T-cell leukemia virus type I-infected T-cell lines: evidence for the involvement of NF-kappa B. Blood 1994, 84, 2904-2911.
217. Liu, S.; Liu, Z.; Xie, Z.; Pang, J.; Yu, J.; Lehmann, E.; Huynh, L.; Vukosavljevic, T.; Takeki, M.; Klisovic, R.B. et al. Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia. Blood 2008, 111, 2364-2373.
218. Nicot, C.; Mahieux, R., Pise-Masison, C.; Brady, J.; Gessain, A.; Yamaoka, S.; Franchini, G. Human T-cell lymphotropic virus type 1 Tax represses c-Myb-dependent transcription through activation of the NF-kappaB pathway and modulation of coactivator usage. Mol. Cell Biol. 2001, 21, 7391-7402.
219. Uittenbogaard, M.N.; Armstron, A.P.; Chiaramello, A.; Nyborg, J.K. Human T-cell leukemia virus type I Tax protein represses gene expression through the basic helix-loop-helix family of transcription factors. J. Biol. Chem. 1994, 269, 22466-22469.
220. Uittenbogaard, M.N.; Giebler, H.A.; Reisman, D.; Nyborg, J.K. Transcriptional repression of p53 by human T-cell leukemia virus type I Tax protein. J. Biol. Chem. 1995, 270, 28503-28506.
221. Ravi, R.; Mookerjee, B.; van Hensbergen, Y.; Bedi, G.C.; Giordano, A.; El-Deiry, W.S.; Fuchs, E.J.; Bedi, A. p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. Cancer Res. 1998, 58, 4531-4536.
222. Wadgaonkar, R.; Phelps, K.M.; Haque, Z.; Williams, A.J.; Silverman, E.S.; Collins, T. CREB-binding protein is a nuclear integrator of nuclear factor-kappaB and p53 signaling. J. Biol. Chem. 1999, 274, 1879-1882.
223. Webster, G.A.; Perkins, N.D. Transcriptional cross talk between NF-kappaB and p53. Mol. Cell Biol. 1999, 19, 3485-3495.
224. Jeong, S.J.; Radonovich, M.F.; Brady, J.N.; Pise-Masison, C.A. HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity. Blood 2004, 104, 1490-1497.
225. Pise-Masison, C.A.; Mahieux, R.; Jiang, H.; Ashcroft, M.; Radonovich, M.F.; Duvall, J.; Guillerm, C.; Brady, J.N. Inactivation of p53 by human T-cell lymphotropic virus type 1 Tax requires activation of the NF-kappaB pathway and is dependent on p53 phosphorylation. Mol Cell Biol. 2000, 20, 3377-3386.
226. Jeong, S.J.; Pise-Masison, C.A.; Radonovich, M.F.; Park, H.U.; Brady, J.N. A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity. J. Biol. Chem. 2005, 280, 10326-10332.
227. Xia, Y.; Padre, R.C.; De Mendoza, T.H.; Bottero, V,; Tergaonkar, V.B.; Verma, I.M. Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP. Proc. Natl. Acad Sci. U. S. A. 2009, 106, 2629-2634.
228. Tergaonkar, V.; Pando, M.; Vafa, O.; Wahl, G.; Verma, I. p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy. Cancer Cell 2002, 1, 493-503.
229. Busuttil, V.; Droin, N.; McCormick, L.; Bernassola, F.; Candi, E.; Melino, G.; Green, D.R. NF-kappaB inhibits T-cell activation-induced, p73-dependent cell death by induction of MDM2. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 18061-18066.
230. Bellon, M.; Nicot, C. Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cells. Blood 2008, 112, 2946-2955.
231. Sinha-Datta, U.; Horikawa, I., Michishita, E.; Datta, A.; Sigler-Nicot, J.C.; Brown, M.; Kazanji, M.; Barrett, J.C.; Nicot, C. Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells. Blood 2004, 104, 2523-2531.
232. Mori, N.; Sato, H.; Hayashibara, T.; Senba, M.; Hayashi, T.; Yamada, Y.; Kamihira, S.; Ikeda, S.; Yamasaki, Y.; Morikawa, S. et al. Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness. Blood 2002, 99, 1341-1349.
233. Okayama, A.; Chen, Y.M.; Tachibana, N.; Shioiri, S.; Lee, T.H.; Tsuda, K.; Essex, M. High incidence of antibodies to HTLV-I tax in blood relatives of adult T cell leukemia patients. J. Infect. Dis. 1991, 163, 47-52.
234. Tochikura, T.; Iwahashi, M.; Matsumoto, T.; Koyanagi, Y.; Hinuma, Y; Yamamoto, N. Effect of human serum anti-HTLV antibodies on viral antigen induction in vitro cultured peripheral lymphocytes from adult T-cell leukemia patients and healthy virus carriers. Int. J. Cancer 1985, 36, 1-7.
235. Hanon, E.; Hall, S.; Taylor, G.P.; Saito, M.; Davis, R.; Tanaka, Y.; Usuku, K.; Osame, M.; Weber, J.N.; Bangham, C.R. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 2000, 95, 1386-1392.
236. Inoue, J.; Seiki, M.; Yoshida, M. The second pX product p27 chi-III of HTLV-1 is required for gag gene expression. FEBS Lett. 1986, 209, 187-190.
237. Hidaka, M.; Inoue, J.; Yoshida, M.; Seiki, M. Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J. 1988, 7, 519-523.
238. Gröne, M.; Koch, C.; Grassmann, R. The HTLV-1 Rex protein induces nuclear accumulation of unspliced viral RNA by avoiding intron excision and degradation. Virology 1996, 218, 316-325.
239. Nicot, C.; Dundr, M.; Johnson, J.M.; Fullen, J.R.; Alonzo, N.; Fukumoto, R.; Princler, G.L.; Derse, D.; Misteli, T.; Franchini, G. HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat. Med. 2004, 10, 197-201.
240. Zhang, W.; Nisbet, J.W.; Albrecht, B.; Ding, W.; Kashanchi, F.; Bartoe, J.T.; Lairmore, M.D. Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300. J. Virol. 2001, 75, 9885-9985.
241. Satou, Y.; Yasunaga J.; Yoshida, M.; Matsuoka, M. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 720-725.
242. Gaudray, G.; Gachon, F.; Basbous, J.; Biard-Piechaczyk, M.; Devaux, C.; Mesnard, J.M. The Complementary Strand of the Human T-Cell Leukemia Virus Type 1 RNA Genome Encodes a bZIP Transcription Factor That Down-Regulates Viral Transcription. J. Virol. 2002, 76, 12813-12822.
243. Arnold, J.; Zimmerman, B., Li, M.; Lairmore, M.D.; Green, P.L. Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood 2008, 112, 3788-3797.
244. Choudhary, G.; Ratner, L. The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30(II) mRNA. Virology 2011, 410, 307-315.
245. Satou, Y.; Yasunaga J.; Zhao, T.; Yoshida, M.; Miyazato, P.; Takai, K.; Shimizu, K.; Ohshima, K.; Green, P.L., Ohkura, N. et al. HTLV-1 bZIP Factor Induces T-Cell Lymphoma and Systemic Inflammation In vivo. PLoS Pathog. 2011, 7, e1001274.
246. Rende, F.; Cavallari, I.; Corradin, A.; Silic-Benussi, M.; Toulza, F.; Toffolo, G.M.; Tanaka, Y.; Jacobson, S.; Taylor, G.P.; D'Agostino, D.M. et al. Kinetics and intracellular compartmentalization of HTLV-1 gene expression: Nuclear retention of HBZ mRNA. Blood 2011, 117, 4855-4859.
247. Saito, M.; Matsuzaki, T.; Satou, Y.; Yasunaga, J.; Saito, K.; Arimura, K.; Matsuoka, M.; Ohara, Y., In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). Retrovirology 2009, 6, 19.
248. Hilburn, S.; Rowan, A.; Demontis, M.A.; MacNamara, A.; Asquith, B.; Bangham, C.R.; Taylor, G.P. In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome. J. Infect. Dis. 2011, 203, 529-536.
249. Arnold, J.; Yamamoto, B.; Li, M.; Phipps, A.J.; Younis, I.; Lairmore, M.D.; Green, P.L. Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood 1996, 107, 3976-3982.
250. Ego, T.; Ariumi, Y.; Shimotohno, K. The interaction of HTLV-1 Tax with HDAC1 negatively regulates the viral gene expression. Oncogene 2002, 21, 7241-7246.
251. Lu, H.; Pise-Masison, C.A.; Linton, R.; Park, H.U.; Schiltz, R.L.; Sartorelli, V.; Brady, J.N. Tax relieves transcriptional repression by promoting histone deacetylase 1 release from the human T-cell leukemia virus type 1 long terminal repeat. J. Virol. 2004, 78, 6735-6743.
252. Yan, P.; Qu, Z.; Ishikawa, C.; Mori, N.; Xiao, G. Human T-cell leukemia virus type I-mediated repression of PDZ-LIM domain-containing protein 2 involves DNA methylation but independent of the viral oncoprotein tax. Neoplasia 2009, 11, 1036-1041.
253. Qu, Z.; Fu, J.; Yan, P.; Hu, J.; Cheng, S.Y.; Xiao, G. Epigenetic repression of PDZ-LIM domain-containing protein 2: implications for the biology and treatment of breast cancer. J. Biol. Chem. 2010, 285, 11786-11792.
254. Qu, Z.; Yan, P.; Fu, J.; Jiang, J.; Grusby, M.J.; Smithgall, T.E.; Xiao, G. DNA methylation-dependent repression of PDZ-LIM domain-containing protein 2 in colon cancer and its role as a potential therapeutic target. Cancer Res. 2010, 70, 1766-1772.
255. Qing, G.; Yan, P.; Qu, Z.; Liu, H.; Xiao, G. Hsp90 regulates processing of NF-kappa B2 p100 involving protection of NF-kappa B-inducing kinase (NIK) from autophagy-mediated degradation. Cell Res. 2007, 17, 520-530.
256. Qing, G.; Yan, P.; Xiao, G. Hsp90 inhibition results in autophagy-mediated proteasome-independent degradation of IkappaB kinase (IKK). Cell Res. 2006, 16, 895-901.
257. Xiao, G. Autophagy and NF-kappaB: fight for fate. Cytokine Growth Factor Rev. 2007, 18, 233-243.
258. Rivera-Walsh, I.; Waterfiled, M.; Xiao, G.; Fong, A.; Sun, S.C. NF-kappaB signaling pathway governs TRAIL gene expression and human T-cell leukemia virus-I Tax-induced T-cell death. J. Biol. Chem. 2001, 276, 40385-40388.
259. Swaims, A.Y.; Khani, F.; Zhang, Y.; Roberts, A.I.; Devadas, S.; Shi, Y.; Rabson, A.B. Immune activation induces immortalization of HTLV-1 LTR-Tax transgenic CD4+ T cells. Blood 2010, 116, 2994-3003.
260. Franchini, G.; Mulloy, J.C.; Koralnik, I.J.; Lo Monico, A.; Sparkowski, J.J.; Andresson, T.; Goldstein, D.J.; Schlegel, R. The human T-cell leukemia/lymphotropic virus type I p12I protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase. J. Virol. 1993, 67, 7701-7704.
261. Derse, D.; Mikovits, J.; Ruscetti, F. X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro. Virology 1997, 237, 123-128.
262. Robek, M.D.; Wong, F.H.; Ratner, L. Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes. J. Virol. 1998, 72, 4458-4462.
263. Ye, J.; Silverman, L.; Lairmore, M.D.; Green, P.L. HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro. Blood 2003, 102, 3963-3969.